Author(s)
Purpose
- Pathology:
Nervous system diseases
Psychiatry/psychology
- Disease:
Alzheimer Disease
- Objective:
To assess the clinical manifestations and cognitive alterations in patients with Alzheimer’s disease
- Population for intended use:
Adult
Geriatrics
[ 50+ years ]
Characteristics
- Type of instrument:
Signs and symptoms
- Administration mode:
Interviewer-administered
- Number of items:
98 (some with subparts)
- Recall/Observation period:
Current
Language(s)
- Original language:
English for the USA
- List of existing translations:
The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.
CERAD-Clinical Battery
| Arabic | Finnish for Finland | Italian for Italy | Portuguese for Portugal |
| Bulgarian | French for France | Japanese for Japan | Spanish for Spain |
| Chinese | German for Germany | Korean | |
| Dutch for the Netherlands | Hebrew | Norwegian for Norway |
The translations may apply to specific CERAD materials.
Bibliographic reference(s) of the original questionnaire
Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits D, Clark C. et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part 1. Clinical and Neuropsychological Assessment of Alzheimer's Disease. Neurology 1989;39:1159-65
Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bonner KA, Heyman A. CERAD (Consortium to Establish a Registry for Alzheimer's Disease): the first 20 years. Alzheimer's and Dementia: The Journal of the Alzheimer's Association 2008;4(2): 96-109
Last update: April 2012
Last update in collaboration with the author: March 2008
